SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-010961
Filing Date
2024-04-17
Accepted
2024-04-17 16:15:29
Documents
1
Period of Report
2024-04-15

Document Format Files

Seq Description Document Type Size
1 form4-04172024_040406.html 4  
1 form4-04172024_040406.xml 4 3978
  Complete submission text file 0001415889-24-010961.txt   5442
Mailing Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 0114318906360
HOOKIPA Pharma Inc. (Issuer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O HOOKIPA PHARMA INC. 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address
Orlinger Klaus (Reporting) CIK: 0001768432 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38869 | Film No.: 24851256